Evidence map›Paper›PMID 26118301›Full record

ReviewThe British journal of radiology2015

Imaging intracellular and systemic in vivo gold nanoparticles to enhance radiotherapy.

S W Botchway, J A Coulter, F J Currell

Open access · hybridAbstract readReview
In one paragraph

Review in The British journal of radiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

S W Botchway1 Science and Technology Facility Council, Research Complex at Harwell, CLF, Rutherford Appleton Laboratory, Harwell Oxford, Didcot, UK.
J A Coulter2 School of Pharmacy, McClay Research Centre, Queen's University Belfast, Belfast, UK.
F J Currell3 School of Mathematics and Physics, Queens University Belfast, Belfast, UK.
Queen's University Belfast · GBScience and Technology Facilities Council · GB

Funding

Medical Research Council G0502183
6 · The paper itself

Abstract

Nanoparticles offer alternative options in cancer therapy both as drug delivery carriers and as direct therapeutic agents for cancer cell inactivation. More recently, gold nanoparticles (AuNPs) have emerged as promising radiosensitizers achieving significantly elevated radiation dose enhancement factors when irradiated with both kilo-electron-volt and mega-electron-volt X-rays. Use of AuNPs in radiobiology is now being intensely driven by the desire to achieve precise energy deposition in tumours. As a consequence, there is a growing demand for efficient and simple techniques for detection, imaging and characterization of AuNPs in both biological and tumour samples. Spatially accurate imaging on the nanoscale poses a serious challenge requiring high- or super-resolution imaging techniques. In this mini review, we discuss the challenges in using AuNPs as radiosensitizers as well as various current and novel imaging techniques designed to validate the uptake, distribution and localization in mammalian cells. In our own work, we have used multiphoton excited plasmon resonance imaging to map the AuNP intracellular distribution. The benefits and limitations of this approach will also be discussed in some detail. In some cases, the same "excitation" mechanism as is used in an imaging modality can be harnessed to make it also a part of therapy modality (e.g. phototherapy)-such examples are discussed in passing as extensions to the imaging modality concerned.

Indexed as

Drug CarriersGoldHumansMetal NanoparticlesNeoplasmsRadiation-Sensitizing AgentsDrug CarriersGoldRadiation-Sensitizing Agents

Identifiers

PMID26118301
PMCPMC4730966
OpenAlexW1946914679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.